Podcast in English
Text size
Bulgarian National Radio © 2024 All Rights Reserved

Russia sends Bulgaria medicine against Covid-19

Photo: ria.ru

The Russian Direct Investment Fund and Russian pharmaceutical company Chemrar have agreed to supply the drug Avifavir against the novel coronavirus to 17 foreign countries, including Bulgaria, TASS has reported, quoted by BTA.

Avifavir has already been delivered to 6 countries. Deliveries are expected for another 17 countries. With the exception of Bulgaria and Serbia, all other countries are from Asia and South America.

In May, Avifavir was registered by the Russian Ministry of Health and became the world's first drug based on the substance favipiravir approved for the treatment of Covid-19. More than 60,000 packs of Avifavir have been delivered across Russia itself, TASS reports.




Последвайте ни и в Google News Showcase, за да научите най-важното от деня!
Listen to the daily news from Bulgaria presented in "Bulgaria Today" podcast, available in Spotify.

More from category

Long lines of trucks and cars at the border with Turkiye

Long lines of trucks and cars have formed at the border with Turkiye, reported Nova TV. The line of trucks on the Maritsa motorway has reached Svilengrad and is over 12 kilometres long, which is due to the increased traffic before the holidays...

published on 12/22/24 5:21 PM

Monday will be cloudy and windy

During the night, the cloud cover will increase from the west, but there will still be no precipitation.  The weather will remain clear in the eastern parts of the country. The lowest temperatures will range from minus 3°C to 2°C, slightly higher in..

published on 12/22/24 5:20 PM

A new lane is being built at Kulata border checkpoint due to Bulgaria's entry into Schengen

The renovation of the Kulata border checkpoint has begun in connection with Bulgaria's upcoming entry into Schengen on January 1. There will be two lanes in each direction before the checkpoint. A new 200-meter lane is being built on Bulgarian..

published on 12/22/24 3:10 PM